학술논문
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy
Document Type
Article
Author
Grebely, Jason; Conway, Brian; Cunningham, Evan B.; Fraser, Chris; Moriggia, Alberto; Gane, Ed; Stedman, Catherine; Cooper, Curtis; Castro, Erika; Schmid, Patrick; Petoumenos, Kathy; Hajarizadeh, Behzad; Marks, Phillipa; Erratt, Amanda; Dalgard, Olav; Lacombe, Karine; Feld, Jordan J.; Bruneau, Julie; Daulouede, Jean-Pierre; Powis, Jeff; Bruggmann, Philip; Matthews, Gail V.; Kronborg, Ian; Shaw, David; Dunlop, Adrian; Hellard, Margaret; Applegate, Tanya L.; Crawford, Sione; Dore, Gregory J
Source
In International Journal of Drug Policy December 2018 62:94-103
Subject
Language
ISSN
0955-3959